clinical trial · NCT05076617
A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
UCB Biopharma SRL·phase3·enrolling by invitation·n = 300
Stereotypical Prolonged SeizuresStaccato alprazolam
brief summary
The purpose of the study is to evaluate the long-term safety and tolerability of Staccato alprazolam.
started
Feb 3, 2022
primary completion
Nov 30, 2028
completion
Nov 30, 2028
last updated
Apr 24, 2026
official title
An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol